These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33226173)

  • 21. Comparative efficacy of topical oclacitinib 0.1% and tacrolimus 0.01% in canine keratoconjunctivitis sicca.
    de Oliveira JK; Williams DL; Bollmann C; de Seabra NM; Bortolini M; Montiani-Ferreira F
    Vet Ophthalmol; 2019 Sep; 22(5):633-643. PubMed ID: 30724448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective investigation into risk factors of sarcoptic mange in dogs.
    Feather L; Gough K; Flynn RJ; Elsheikha HM
    Parasitol Res; 2010 Jul; 107(2):279-83. PubMed ID: 20405144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blinded, randomized, methylprednisolone-controlled study on the efficacy of oclacitinib in the management of pruritus in cats with nonflea nonfood-induced hypersensitivity dermatitis.
    Noli C; Matricoti I; Schievano C
    Vet Dermatol; 2019 Apr; 30(2):110-e30. PubMed ID: 30656750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localised sarcoptic mange in dogs: a retrospective study of 10 cases.
    Pin D; Bensignor E; Carlotti DN; Cadiergues MC
    J Small Anim Pract; 2006 Oct; 47(10):611-4. PubMed ID: 17004955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.
    Ortalda C; Noli C; Colombo S; Borio S
    Vet Dermatol; 2015 Aug; 26(4):235-e52. PubMed ID: 25940959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
    Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
    Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of oclacitinib in the management of ischaemic dermatopathy in four dogs.
    Levy BJ; Linder KE; Olivry T
    Vet Dermatol; 2019 Jun; 30(3):201-e63. PubMed ID: 31006925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of sarcoptic mange in dogs.
    Fourie LJ; Kok DJ; du Plessis A; Rugg D
    Vet Parasitol; 2007 Dec; 150(3):275-81. PubMed ID: 17931787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and Validation of a Canine Pruritic Model.
    Aberg GA; Arulnesan N; Bolger GT; Ciofalo VB; Pucaj K
    Drug Dev Res; 2015 Aug; 76(5):246-50. PubMed ID: 26220424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of ivermectin in the treatment of sarcoptic mange in dogs.
    Scheidt VJ; Medleau L; Seward RL; Schwartzman RM
    Am J Vet Res; 1984 Jun; 45(6):1201-2. PubMed ID: 6377991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of afoxolaner in a clinical field study in dogs naturally infested with Sarcoptes scabiei.
    Beugnet F; de Vos C; Liebenberg J; Halos L; Larsen D; Fourie J
    Parasite; 2016; 23():26. PubMed ID: 27317462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age- and breed-matched retrospective cohort study of malignancies and benign skin masses in 660 dogs with allergic dermatitis treated long-term with versus without oclacitinib.
    Lancellotti BA; Angus JC; Edginton HD; Rosenkrantz WS
    J Am Vet Med Assoc; 2020 Sep; 257(5):507-516. PubMed ID: 32808904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL-31-induced pruritus.
    Fleck T; Norris L; King V; Lesman S; Gonzales AJ
    J Vet Pharmacol Ther; 2022 Jul; 45(4):380-384. PubMed ID: 35586953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcoptic mange in dogs: Its effect on liver, oxidative stress, trace minerals and vitamins.
    Beigh SA; Soodan JS; Bhat AM
    Vet Parasitol; 2016 Aug; 227():30-4. PubMed ID: 27523934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study on the effect of oclacitinib on epicutaneous sensitization and transepidermal water loss in a colony of atopic beagle dogs.
    Marsella R; Ahrens K
    Vet Dermatol; 2018 Oct; 29(5):439-e146. PubMed ID: 29926994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminished antimicrobial drug use in dogs with allergic dermatitis treated with oclacitinib.
    Mwacalimba K; Hillier A; Rosenbaum M; Brennan C; Amodie D
    Front Vet Sci; 2023; 10():1207582. PubMed ID: 37745208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A blinded, randomized, placebo-controlled trial of the safety of oclacitinib in cats.
    Lopes NL; Campos DR; Machado MA; Alves MSR; de Souza MSG; da Veiga CCP; Merlo A; Scott FB; Fernandes JI
    BMC Vet Res; 2019 May; 15(1):137. PubMed ID: 31068210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks.
    Panteri A; Strehlau G; Helbig R; Prost C; Doucette K
    Vet Dermatol; 2016 Feb; 27(1):22-e7. PubMed ID: 26660461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes spp., Demodex spp. and Psoroptes spp. mites.
    Wagner R; Wendlberger U
    Vet Parasitol; 2000 Nov; 93(2):149-58. PubMed ID: 11035233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of an imidacloprid/moxidectin combination against naturally acquired Sarcoptes scabiei infestations on dogs.
    Fourie LJ; Heine J; Horak IG
    Aust Vet J; 2006; 84(1-2):17-21. PubMed ID: 16498829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.